Pendium
Pricing
Get a demo
Dashboard
Dashboard
Loading…
/

Teach AI agents to recommend your brand to the right people.

Scan your visibilityBook a demo
Pendium
𝕏

Product

AI Visibility ScanYelp Listing AuditSite AuditContent for AI AgentsAgent Experience EngineAgent AnalyticsPricing

Industries

Local BusinessesRestaurantsHome ServicesBeauty & SpasHealth & MedicalFitness & GymsPet ServicesContractorsBars & NightlifeMoving CompaniesAuto DealershipsSaaS CompaniesSEO TeamsMarketing Teams

Tools

AI Visibility Site ScanYelp Listing AuditGBP AuditSocial Presence AuditBlog That Writes Itself

Real Life Examples

RipplingMasterclassThorneMonday.comPatagonia

Company

AboutBook a DemoDocsPrivacy PolicyTerms of Service
© 2026 Manifest Labs. All rights reserved.
PrivacyTerms
Strand AI
Strand AI
Visibility15
Vibe72
Businesses/Biotechnology & Life Sciences/Strand AI
Strand AI
AI Visibility & Sentiment

Strand AI

Strand AI is a biotechnology company that uses multimodal AI to predict missing biological data from existing patient information. They help pharmaceutical companies and researchers rescue incomplete clinical trial cohorts, skip expensive assays, and discover biomarkers that were never measured.

Active Monitoring
strandai.com
Biotechnology & Life SciencesYC25-26
AI Visibility Score
15/100

Invisible

Sentiment Score
72/100
Score by Priority

How often this business is recommended to users across different types of conversations — from direct product queries to broader open-ended conversations where AI could recommend this company's products and services

core
15
adjacent
14
aspirational
0
OverviewLandscapeInsights & ActionsConversationsCitationsBrand Voice

Is this your business?

AI Perception

Key Takeaways

How AI platforms collectively perceive and describe Strand AI today.

Strand AI is currently a ghost within the OpenAI ecosystem and Google's AI Overviews, leaving a massive power vacuum that competitors like Owkin and Recursion are aggressively filling. While the brand maintains a surgical strike capability within Claude for high-intent bioinformatics queries, it is virtually non-existent to Clinical Trial Directors and Academic PIs who are shaping the next wave of biotech investment.

Working in your favor

Strong niche resonance with the Bioinformatics Strategy Lead persona, achieving a 56% mention rate.

High-authority placement in Claude for technical solutions, specifically ranking #1 for clinical trial data imputation and #3 for cohort rescue.

Positive sentiment across most successful mentions, indicating that when the brand is surfaced, the AI perceives it as a credible solution.

Gaps to close

Complete invisibility in ChatGPT and AI Overviews, which represent the primary discovery engines for executive decision-makers.

Total failure to capture the 'Cross-Modal Biological Prediction' and 'Multimodal Data' categories, where Owkin and Tempus are currently dominating.

Zero visibility for Clinical Trial Optimization Directors, a critical buyer persona that appears to be entirely underserved by Strand's current digital footprint.

Opportunities

Capture the 'AI Biotech Trust' category by optimizing for multimodal data queries where no single competitor has established absolute dominance.

Leverage the brand's technical success in Claude to reverse-engineer content strategies for Gemini and ChatGPT.

Target the 'proteomics from H&E slides' query space, as this high-value technical gap is currently wide open for an authoritative brand to claim.

Highest-Impact Actions
1

Execute an OpenAI-specific technical SEO audit to break the 0% mention rate in ChatGPT.

ChatGPT is the most used LLM for business intelligence; being invisible here is a critical failure that allows competitors to own the market narrative.

2

Develop and publish deep-dive technical whitepapers on 'Cross-Modal Biological Prediction' and 'Proteomics Prediction'.

The brand is currently missing 100% of these high-intent technical queries, which are essential for establishing category leadership in multimodal AI.

3

Create persona-specific case studies tailored to Clinical Trial Optimization Directors focusing on 'Cohort Rescue'.

Despite having a product that solves this problem, the brand has 0% visibility with this persona, while competitors like SAS and Tempus are being recommended.

Value Proposition

Predict missing biological modalities from existing patient data, enabling researchers to rescue incomplete cohorts, skip expensive assays, and discover hidden biomarkers without re-acquisition.

Overview

Strand AI is a biotechnology company that uses multimodal AI to predict missing biological data from existing patient information. They help pharmaceutical companies and researchers rescue incomplete clinical trial cohorts, skip expensive assays, and discover biomarkers that were never measured.

Mission

Filling in the gaps in multimodal patient data so researchers can find what they're looking for and improve clinical trial outcomes.

Products & Services
Cross-modal biological prediction platformVariantFormer gene expression imputationProteomics and transcriptomics prediction from H&E slidesBiomarker discovery and imputationClinical trial cohort rescue tools
Current State

Visibility Landscape

A high-level view of how Strand AI performs across AI platforms, broken down by strategic priority level — from core brand queries to growth opportunities.

ChatGPTChatGPT
ClaudeClaude
GeminiGemini
AI OverviewsAI Overviews

Reputation1q

Brand recognition & direct queries

97
97
70
70
“What do you know about Strand AI? What do they do and what's their reputation?”
#1
#1
Yes
#12

Core2q

Product/service category queries

0
91
38
0
“can I predict proteomics from H&E slides using AI, which platforms do this well”
No
#5
No
No
“help me find tools for clinical trial data imputation, what specific platforms should i look into”
—
#1
#9
No

Growth Areas2q

Adjacent, aspirational & visionary

0
56
35
0
“how to rescue a clinical trial cohort that has missing biological data”
No
#3
#12
No
“most reliable AI biotech companies for multimodal data”
No
No
No
No
ChatGPT
Claude
Gemini
AI Overviews

“What do you know about Strand AI? What do they do and what's their reputation?”

ChatGPT#1
Claude#1
GeminiYes
AI Overviews#12

“can I predict proteomics from H&E slides using AI, which platforms do this well”

ChatGPTNo
Claude#5
GeminiNo
AI OverviewsNo

“help me find tools for clinical trial data imputation, what specific platforms should i look into”

ChatGPT—
Claude#1
Gemini#9
AI OverviewsNo

“how to rescue a clinical trial cohort that has missing biological data”

ChatGPTNo
Claude#3
Gemini#12
AI OverviewsNo

“most reliable AI biotech companies for multimodal data”

ChatGPTNo
ClaudeNo
GeminiNo
AI OverviewsNo
Competitive Landscape
1
Owkin
16 mentions
2
SAS
10 mentions
3
Tempus
9 mentions
4
Olink
9 mentions
5
PathAI
8 mentions
6
Recursion Pharmaceuticals
8 mentions
7
Tempus AI
8 mentions
8
Insitro
7 mentions
9
NVIDIA
6 mentions
10
missForest
5 mentions
11
Strand AI
5 mentions
Analysis

Insights & Recommended Actions

What's working, what's not, and specific steps to improve Strand AI's AI visibility.

Key Findings

Strength

Strong niche resonance with the Bioinformatics Strategy Lead persona, achieving a 56% mention rate.

Strength

High-authority placement in Claude for technical solutions, specifically ranking #1 for clinical trial data imputation and #3 for cohort rescue.

Strength

Positive sentiment across most successful mentions, indicating that when the brand is surfaced, the AI perceives it as a credible solution.

Recommended Actions

1

Execute an OpenAI-specific technical SEO audit to break the 0% mention rate in ChatGPT.

ChatGPT is the most used LLM for business intelligence; being invisible here is a critical failure that allows competitors to own the market narrative.

2

Develop and publish deep-dive technical whitepapers on 'Cross-Modal Biological Prediction' and 'Proteomics Prediction'.

The brand is currently missing 100% of these high-intent technical queries, which are essential for establishing category leadership in multimodal AI.

3

Create persona-specific case studies tailored to Clinical Trial Optimization Directors focusing on 'Cohort Rescue'.

Despite having a product that solves this problem, the brand has 0% visibility with this persona, while competitors like SAS and Tempus are being recommended.

Programmatic Testing

Sample Conversations

We programmatically analyze questions that real customers are asking to AI agents and chatbots, extract brand mentions and sentiment, analyze every response, and synthesize the data into an action plan to increase AI visibility.

ChatGPTChatGPTClaudeClaudeGeminiGeminiAI OverviewsAI Overviews
Clinical Trial Cohort Rescue(2 queries)

“how to rescue a clinical trial cohort that has missing biological data”

0/4 platforms mentioned

Adjacent
ChatGPTChatGPT
1.REDCap
2.naniar
3.VIM
4.UpSetR
5.LabCorp

+20 more

ClaudeClaude
1.REDCap
2.SAS
3.SPSS
4.R
5.STROBE-MD

+2 more

GeminiGemini
1.SAS
2.R Project
3.Stata
4.Precision for Medicine
5.Quanterix

+10 more

AI OverviewsAI Overviews
1.Veranex

“help me find tools for clinical trial data imputation, what specific platforms should i look into”

2/3 platforms mentioned

Core
The Bioinformatics Strategy Lead · Head of Bioinformatics
ClaudeClaude
1.Strand AI
2.Olink
3.10x
4.Python
5.Certara's Actuate

+6 more

GeminiGemini
1.10x Genomics
2.Olink
3.scVI-tools
4.Gretel.ai
5.DataWig
9.Strand AI

+3 more

AI OverviewsAI Overviews
1.SAS
2.Pharmaverse
3.mice
4.rbmi
5.mmrm

+7 more

Source Intelligence

Citations

The sources AI platforms cite when recommending this brand. Pendium reverse-engineers what's already proven to be catnip to AI agents, then engineers content that fills gaps and helps agents do their job — which means more citations for you.

Missing Data in Clinical Studies: Issues and Methods - PMC

pmc.ncbi.nlm.nih.gov

Gov1 ref

Missing Data in Clinical Research: A Tutorial on Multiple ...

pmc.ncbi.nlm.nih.gov

Gov1 ref

Strategies for Successful Clinical Data Management Rescue ...

veranex.com

Social1 ref

Considerations to address missing data when deriving clinical ...

sciencedirect.com

Web1 ref

Comparison of different approaches in handling missing data ... - PMC

pmc.ncbi.nlm.nih.gov

Gov1 ref

Trial Strategies to Reduce the Frequency of Missing Data - NCBI

ncbi.nlm.nih.gov

Gov1 ref

The prevention and handling of the missing data - PMC

pmc.ncbi.nlm.nih.gov

Gov1 ref

Strategies for Handling Missing Data in Electronic Health Record ...

pmc.ncbi.nlm.nih.gov

Gov1 ref

Clinical Trial Rescue: How to Recover a Failing Study

cromospharma.com

Web1 ref

Minimizing Missing Data in Clinical Trials | Circulation

ahajournals.org

Web1 ref

Methods to Handle Incomplete Data - MAMC Journal of Medical Sciences

journals.lww.com

Web1 ref

Research White Paper Managing Missing Data in Patient ...

effectivehealthcare.ahrq.gov

Gov1 ref

A review of the reporting and handling of missing data in cohort ...

pmc.ncbi.nlm.nih.gov

Gov1 ref

Problems in dealing with missing data and informative censoring in ...

pmc.ncbi.nlm.nih.gov

Gov1 ref

AI turns routine pathology slides into powerful maps of the ...

news-medical.net

Web1 ref
Brand Identity

Brand Voice & Style

How AI perceives Strand AI's communication style and personality

Strand AI communicates with scientific precision and technical authority while remaining accessible to their specialized audience. Their voice is confident and solution-oriented, directly addressing the pain points of clinical researchers without unnecessary jargon. They balance technical credibility with clarity, using concrete examples and data points to demonstrate value. The tone is professional and forward-thinking, positioning themselves as innovators solving real problems in drug development.

Core Tone Traits

Scientifically Authoritative

Uses precise technical language and references specific biological modalities, demonstrating deep domain expertise

Solution-Oriented

Focuses on solving concrete problems like incomplete cohorts and expensive assays rather than abstract capabilities

Data-Driven

Leads with statistics and evidence, such as the 90% clinical trial failure rate, to establish credibility

Accessible Technical

Explains complex concepts clearly without dumbing down, respecting the audience's intelligence

Visual Identity

Primary

#1B5E3C

Secondary

#E8F0E8

Accent

#FFFFFF

Background

#FFFFFF

Foreground

#111111

Backing

Investors

Y
Y Combinator

Engineer content that makes AI agents recommend you

Pendium analyzes how AI platforms perceive your brand, reverse-engineers what they already cite, and continuously publishes content designed to fill gaps and earn more mentions — on autopilot, with you in the loop.

Data generated by Pendium.ai AI visibility scanning. Last scanned February 27, 2026.

Start getting
recommended by AI.

Enter your website to see exactly what ChatGPT, Claude, and Gemini say about your business. Free, instant, and eye-opening.

Free visibility scanResults in 2 minutesNo credit card required

Frequently asked questions

Don't see your question? Book a demo and we'll walk you through it.

Strand AI is a biotechnology company that uses multimodal AI to predict missing biological data from existing patient information. They help pharmaceutical companies and researchers rescue incomplete clinical trial cohorts, skip expensive assays, and discover biomarkers that were never measured.

Predict missing biological modalities from existing patient data, enabling researchers to rescue incomplete cohorts, skip expensive assays, and discover hidden biomarkers without re-acquisition.

AI Visibility Score

Strand AI has an AI visibility score of 15/100, rated as invisible. This score reflects how often and how prominently Strand AI appears in responses from AI assistants like ChatGPT, Claude, and Gemini.

AI Perception Summary

Strand AI is currently a ghost within the OpenAI ecosystem and Google's AI Overviews, leaving a massive power vacuum that competitors like Owkin and Recursion are aggressively filling. While the brand maintains a surgical strike capability within Claude for high-intent bioinformatics queries, it is virtually non-existent to Clinical Trial Directors and Academic PIs who are shaping the next wave of biotech investment.

Strengths

  • Strong niche resonance with the Bioinformatics Strategy Lead persona, achieving a 56% mention rate.
  • High-authority placement in Claude for technical solutions, specifically ranking #1 for clinical trial data imputation and #3 for cohort rescue.
  • Positive sentiment across most successful mentions, indicating that when the brand is surfaced, the AI perceives it as a credible solution.

Visibility Gaps

  • Complete invisibility in ChatGPT and AI Overviews, which represent the primary discovery engines for executive decision-makers.
  • Total failure to capture the 'Cross-Modal Biological Prediction' and 'Multimodal Data' categories, where Owkin and Tempus are currently dominating.
  • Zero visibility for Clinical Trial Optimization Directors, a critical buyer persona that appears to be entirely underserved by Strand's current digital footprint.

Competitors in AI Recommendations

  • Owkin: 16 mentions
  • SAS: 10 mentions
  • Tempus: 9 mentions
  • Olink: 9 mentions
  • PathAI: 8 mentions
  • Recursion Pharmaceuticals: 8 mentions
  • Tempus AI: 8 mentions
  • Insitro: 7 mentions
  • NVIDIA: 6 mentions
  • missForest: 5 mentions
  • scikit-learn: 5 mentions
  • IQVIA: 5 mentions
  • HE2RNA: 5 mentions
  • PyTorch: 5 mentions
  • TCGA: 5 mentions

Categories: Biotechnology & Life Sciences

Tags: YC25-26